Identification of Protein Kinase Inhibitors with a Selective Negative Effect on the Viability of Epstein-Barr Virus Infected B Cell Lines

por Mavromatidis, Vassilis, Varga, Zoltan, Waczek, Frigyes, Őrfi, Zoltán, Őrfi, László, Kéri, György, Mosialos, George
Publicado 2014

Production of NOS2 and inflammatory cytokines is reduced by selected protein kinase inhibitors with partial repolarization of HL-60 derived and human blood macrophages

por Bögel, Gábor, Murányi, József, Szokol, Bálint, Kukor, Zoltán, Móra, István, Kardon, Tamás, Őrfi, László, Hrabák, András
Publicado 2021

Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells

por Hodrea, Judit, Tran, Minh Ngoc, Besztercei, Balazs, Medveczki, Timea, Szabo, Attila J., Orfi, Laszlo, Kovacs, Illes, Fekete, Andrea
Publicado 2023

Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques

por Molnar, Agnes, Lakat, Tamas, Hosszu, Adam, Szebeni, Beata, Balogh, Anna, Orfi, Laszlo, Szabo, Attila J., Fekete, Andrea, Hodrea, Judit
Publicado 2021

Mito-oncology agent: fermented extract suppresses the Warburg effect, restores oxidative mitochondrial activity, and inhibits in vivo tumor growth

por Bencze, Gyula, Bencze, Szilvia, Rivera, Keith D., Watson, James D., Hidvegi, Mate, Orfi, Laszlo, Tonks, Nicholas K., Pappin, Darryl J.
Publicado 2020

Author Correction: Mito-oncology agent: fermented extract suppresses the Warburg effect, restores oxidative mitochondrial activity, and inhibits in vivo tumor growth

por Bencze, Gyula, Bencze, Szilvia, Rivera, Keith D., Watson, James D., Hidvegi, Mate, Orfi, Laszlo, Tonks, Nicholas K., Pappin, Darryl J.
Publicado 2021

Transient Agarose Spot (TAS) Assay: A New Method to Investigate Cell Migration

por Veres-Székely, Apor, Pap, Domonkos, Szebeni, Beáta, Őrfi, László, Szász, Csenge, Pajtók, Csenge, Lévai, Eszter, Szabó, Attila J., Vannay, Ádám
Publicado 2022

Development of a 3D Tissue Culture–Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases

por Booij, Tijmen H., Klop, Maarten J. D., Yan, Kuan, Szántai-Kis, Csaba, Szokol, Balint, Orfi, Laszlo, van de Water, Bob, Keri, Gyorgy, Price, Leo S.
Publicado 2016

Tetralone derivatives are MIF tautomerase inhibitors and attenuate macrophage activation and amplify the hypothermic response in endotoxemic mice

por Garai, János, Krekó, Marcell, Őrfi, László, Jakus, Péter Balázs, Rumbus, Zoltán, Kéringer, Patrik, Garami, András, Vámos, Eszter, Kovács, Dominika, Bagóné Vántus, Viola, Radnai, Balázs, Lóránd, Tamás
Publicado 2021

Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells

por Dolman, ME (Emmy) M, Harmsen, Stefan, Pieters, Ebel HE, Sparidans, Rolf W, Lacombe, Marie, Szokol, Bálint, Őrfi, László, Kéri, György, Storm, Gert, Hennink, Wim E, Kok, Robbert J
Publicado 2012

Targeted drug combination therapy design based on driver genes

por Zsákai, Lilian, Sipos, Anna, Dobos, Judit, Erős, Dániel, Szántai-Kis, Csaba, Bánhegyi, Péter, Pató, János, Őrfi, László, Matula, Zsolt, Mikala, Gábor, Kéri, György, Peták, István, Vályi-Nagy, István
Publicado 2019

EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas

por Nelhűbel, Györgyi A., Cserepes, Mihály, Szabó, Balázs, Türk, Dóra, Kárpáti, Adél, Kenessey, István, Rásó, Erzsébet, Barbai, Tamás, Hegedűs, Zita, László, Viktória, Szokol, Bálint, Dobos, Judit, Őrfi, László, Tóvári, József
Publicado 2021

Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility

por Szabó, Zoltán-István, Orbán, György, Borbás, Enikő, Csicsák, Dóra, Kádár, Szabina, Fiser, Béla, Dobó, Máté, Horváth, Péter, Kiss, Eszter, Budai, Lívia, Dobos, Judit, Pálla, Tamás, Őrfi, László, Völgyi, Gergely, Tóth, Gergő
Publicado 2021

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models

por Gómez, Valentí, Galazi, Myria, Weitsman, Gregory, Monypenny, James, Al-Salemee, Fahad, Barber, Paul R., Ng, Kenrick, Beatson, Richard, Szokol, Bálint, Orfi, László, Mullen, Greg, Vanhaesebroeck, Bart, Chowdhury, Simon, Leung, Hing Y., Ng, Tony
Publicado 2022

Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters

por Temesszentandrási-Ambrus, Csilla, Tóth, Szilárd, Verma, Rinkee, Bánhegyi, Péter, Szabadkai, István, Baska, Ferenc, Szántai-Kis, Csaba, Hartkoorn, Ruben C., Lingerfelt, Mary A., Sarkadi, Balázs, Szakács, Gergely, Őrfi, László, Nagaraja, Valakunja, Ekins, Sean, Telbisz, Ágnes
Publicado 2018

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma

por Brägelmann, Johannes, Dammert, Marcel A., Dietlein, Felix, Heuckmann, Johannes M., Choidas, Axel, Böhm, Stefanie, Richters, André, Basu, Debjit, Tischler, Verena, Lorenz, Carina, Habenberger, Peter, Fang, Zhizhou, Ortiz-Cuaran, Sandra, Leenders, Frauke, Eickhoff, Jan, Koch, Uwe, Getlik, Matthäus, Termathe, Martin, Sallouh, Muhammad, Greff, Zoltán, Varga, Zoltán, Balke-Want, Hyatt, French, Christopher A., Peifer, Martin, Reinhardt, H. Christian, Örfi, László, Kéri, György, Ansén, Sascha, Heukamp, Lukas C., Büttner, Reinhard, Rauh, Daniel, Klebl, Bert M., Thomas, Roman K., Sos, Martin L.
Publicado 2017